Radiographic classification of mandibular osteoradionecrosis: A blinded prospective multi-disciplinary interobserver diagnostic performance study

下颌骨放射性骨坏死的放射学分型:一项盲法前瞻性多学科观察者间诊断性能研究

阅读:1

Abstract

BACKGROUND & PURPOSE: Osteoradionecrosis (ORN) of the jaw is a severe complication affecting up to 15% of head and neck cancer patients treated with radiotherapy. The ClinRad system, endorsed by ASCO/ISOO/MASCC, incorporates radiographic features for ORN severity classification, but variability in imaging use and specialty expertise may impact diagnostic accuracy. This study benchmarks physician performance in diagnosing and staging ORN across specialties and imaging modalities. MATERIALS & METHODS: A retrospective diagnostic validation study was conducted at MD Anderson Cancer Center, involving 20 physicians from oral oncology, radiation oncology, surgery, and neuroradiology. Participants reviewed 85 de-identified imaging sets (CT and orthopantogram (OPG)) from 30 patients with confirmed ORN, diagnosing and staging cases using the ClinRad system. ROC analysis assessed diagnostic accuracy, while intra- and inter-observer agreement was measured using Cohen's and Fleiss kappa statistics. RESULTS: Paired CT-OPG imaging significantly improved diagnostic performance across specialties (p < 0.001), with AUC values ranging from 0.79 (residents) to 0.98 (surgeons). However, inter- and intra-rater agreement remained low, with median Fleiss kappa values of 0.22, 0.13, and 0.05 for ClinRad stages 0/1, 2, and 3, respectively. No specialty demonstrated significantly superior diagnostic accuracy (p > 0.05). CONCLUSION: This study establishes a benchmark for radiographic ORN detection, revealing diagnostic variability across specialties. Findings emphasize the need for standardized imaging protocols, interdisciplinary training, and multimodal imaging to improve diagnostic accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。